These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 16142327)
1. The cooperative transforming effects of PAX3-FKHR and IGF-II on mouse myoblasts. Wang W; Slevin M; Kumar S; Kumar P Int J Oncol; 2005 Oct; 27(4):1087-96. PubMed ID: 16142327 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma. Wang W; Kumar P; Wang W; Epstein J; Helman L; Moore JV; Kumar S Cancer Res; 1998 Oct; 58(19):4426-33. PubMed ID: 9766674 [TBL] [Abstract][Full Text] [Related]
3. Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma. Taulli R; Scuoppo C; Bersani F; Accornero P; Forni PE; Miretti S; Grinza A; Allegra P; Schmitt-Ney M; Crepaldi T; Ponzetto C Cancer Res; 2006 May; 66(9):4742-9. PubMed ID: 16651427 [TBL] [Abstract][Full Text] [Related]
4. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines. Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930 [TBL] [Abstract][Full Text] [Related]
5. Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations. Ren YX; Finckenstein FG; Abdueva DA; Shahbazian V; Chung B; Weinberg KI; Triche TJ; Shimada H; Anderson MJ Cancer Res; 2008 Aug; 68(16):6587-97. PubMed ID: 18701482 [TBL] [Abstract][Full Text] [Related]
6. Structural and functional studies of FKHR-PAX3, a reciprocal fusion gene of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma. Hu Q; Yuan Y; Wang C PLoS One; 2013; 8(6):e68065. PubMed ID: 23799156 [TBL] [Abstract][Full Text] [Related]
7. PAX3/forkhead homolog in rhabdomyosarcoma oncoprotein activates glucose transporter 4 gene expression in vivo and in vitro. Armoni M; Quon MJ; Maor G; Avigad S; Shapiro DN; Harel C; Esposito D; Goshen Y; Yaniv I; Karnieli E J Clin Endocrinol Metab; 2002 Nov; 87(11):5312-24. PubMed ID: 12414908 [TBL] [Abstract][Full Text] [Related]
8. Analysis of genetic events that modulate the oncogenic and growth suppressive activities of the PAX3-FKHR fusion oncoprotein. Xia SJ; Rajput P; Strzelecki DM; Barr FG Lab Invest; 2007 Apr; 87(4):318-25. PubMed ID: 17297479 [TBL] [Abstract][Full Text] [Related]
9. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma. Ahn EH Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752 [TBL] [Abstract][Full Text] [Related]
10. The PAX3-FKHR fusion gene of rhabdomyosarcoma cooperates with loss of p16INK4A to promote bypass of cellular senescence. Linardic CM; Naini S; Herndon JE; Kesserwan C; Qualman SJ; Counter CM Cancer Res; 2007 Jul; 67(14):6691-9. PubMed ID: 17638879 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube. Finckenstein FG; Davicioni E; Osborn KG; Cavenee WK; Arden KC; Anderson MJ Transgenic Res; 2006 Oct; 15(5):595-614. PubMed ID: 16952014 [TBL] [Abstract][Full Text] [Related]
12. Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR transcription target that promotes survival and motility in alveolar rhabdomyosarcoma cells. Zhang Y; Wang C Oncogene; 2011 Aug; 30(32):3549-62. PubMed ID: 21423212 [TBL] [Abstract][Full Text] [Related]
13. An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3-FKHR oncogene. Fredericks WJ; Ayyanathan K; Herlyn M; Friedman JR; Rauscher FJ Mol Cell Biol; 2000 Jul; 20(14):5019-31. PubMed ID: 10866659 [TBL] [Abstract][Full Text] [Related]
14. The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Scheidler S; Fredericks WJ; Rauscher FJ; Barr FG; Vogt PK Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9805-9. PubMed ID: 8790412 [TBL] [Abstract][Full Text] [Related]
15. Alveolar rhabdomyosarcoma-associated proteins PAX3/FOXO1A and PAX7/FOXO1A suppress the transcriptional activity of MyoD-target genes in muscle stem cells. Calhabeu F; Hayashi S; Morgan JE; Relaix F; Zammit PS Oncogene; 2013 Jan; 32(5):651-62. PubMed ID: 22710712 [TBL] [Abstract][Full Text] [Related]
16. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Khan J; Bittner ML; Saal LH; Teichmann U; Azorsa DO; Gooden GC; Pavan WJ; Trent JM; Meltzer PS Proc Natl Acad Sci U S A; 1999 Nov; 96(23):13264-9. PubMed ID: 10557309 [TBL] [Abstract][Full Text] [Related]
17. High expression of the PAX3-FKHR oncoprotein is required to promote tumorigenesis of human myoblasts. Xia SJ; Holder DD; Pawel BR; Zhang C; Barr FG Am J Pathol; 2009 Dec; 175(6):2600-8. PubMed ID: 19893043 [TBL] [Abstract][Full Text] [Related]
18. PAX-FKHR function as pangenes by simultaneously inducing and inhibiting myogenesis. Graf Finckenstein F; Shahbazian V; Davicioni E; Ren YX; Anderson MJ Oncogene; 2008 Mar; 27(14):2004-14. PubMed ID: 17922034 [TBL] [Abstract][Full Text] [Related]
19. Investigation of PAX3/7-FKHR fusion genes and IGF2 gene expression in rhabdomyosarcoma tumors. de Souza RR; Oliveira ID; Caran EM; Alves MT; Abib S; Toledo SR Growth Horm IGF Res; 2012 Dec; 22(6):245-9. PubMed ID: 23079386 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional regulation of IGF-I receptor gene expression by the PAX3-FKHR oncoprotein. Ayalon D; Glaser T; Werner H Growth Horm IGF Res; 2001 Oct; 11(5):289-97. PubMed ID: 11735247 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]